MiR-193b regulates breast cancer cell migration and vasculogenic mimicry by targeting dimethylarginine dimethylaminohydrolase 1
Abstract Dimethylarginine dimethylaminohydrolase 1 (DDAH1) is responsible for metabolism of an endogenous inhibitor of nitric oxide synthase (NOS), asymmetric dimethylarginine (ADMA), which plays a key role in modulating angiogenesis. In addition to angiogenesis, tumours can establish a vascular net...
Guardado en:
Autores principales: | Julie-Ann Hulin, Sara Tommasi, David Elliot, Dong Gui Hu, Benjamin C. Lewis, Arduino A. Mangoni |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Nature Portfolio
2017
|
Materias: | |
Acceso en línea: | https://doaj.org/article/9458664a66d5495589105adce62f38ad |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Human dimethylarginine dimethylaminohydrolase 1 inhibition by proton pump inhibitors and the cardiovascular risk marker asymmetric dimethylarginine: in vitro and in vivo significance
por: S. Tommasi, et al.
Publicado: (2017) -
A functional variant of the dimethylarginine dimethylaminohydrolase-2 gene is associated with insulin sensitivity.
por: Francesco Andreozzi, et al.
Publicado: (2012) -
Cerebral changes occurring in arginase and dimethylarginine dimethylaminohydrolase (DDAH) in a rat model of sleeping sickness.
por: Donia Amrouni, et al.
Publicado: (2011) -
Vasculogenic mimicry formation in EBV-associated epithelial malignancies
por: Tong Xiang, et al.
Publicado: (2018) -
Structural and functional identification of vasculogenic mimicry in vitro
por: Dusan Racordon, et al.
Publicado: (2017)